These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292 [TBL] [Abstract][Full Text] [Related]
4. [Collection and transfusion of peripheral blood stem cells]. Höcker P; Wagner A Beitr Infusionsther; 1991; 28():242-6. PubMed ID: 1725629 [TBL] [Abstract][Full Text] [Related]
5. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration. Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222 [TBL] [Abstract][Full Text] [Related]
6. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784 [TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry quality control in stem cell separation]. Zingsem J; Serke S; Weisbach V; Zimmermann R; Zeiler T; Kampe D; Kunhardt O; Eckstein R Beitr Infusionsther Transfusionsmed; 1994; 32():405-7. PubMed ID: 9480133 [TBL] [Abstract][Full Text] [Related]
8. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735 [TBL] [Abstract][Full Text] [Related]
9. [Clinical use of peripheral stem cells for autologous transplantation]. Zingsem J; Zeiler T; Weisbach V; Holfeld-Ozuysal C; Zimmermann R; Heuft HG; Beyer J; Schwerdtfeger R; Eckstein R Beitr Infusionsther; 1991; 28():251-3. PubMed ID: 1725632 [TBL] [Abstract][Full Text] [Related]
10. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors. Allan DS; Dubé P; Roy J; Busque L; Roy DC Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249 [TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254 [TBL] [Abstract][Full Text] [Related]
12. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol. Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937 [No Abstract] [Full Text] [Related]
13. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347 [TBL] [Abstract][Full Text] [Related]
14. Successful blood stem cell collection and transplant in children weighing less than 25 kg. Deméocq F; Kanold J; Chassagne J; Bezou MJ; Lutz P; deLumley L; Philip I; Vannier JP; Margueritte G; Lamagnére JP Bone Marrow Transplant; 1994 Jan; 13(1):43-50. PubMed ID: 7912601 [TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy. Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470 [TBL] [Abstract][Full Text] [Related]
16. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells. van Besien K; Margolin K; Champlin R; Forman S Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395 [TBL] [Abstract][Full Text] [Related]
17. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874 [TBL] [Abstract][Full Text] [Related]
18. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections. Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956 [TBL] [Abstract][Full Text] [Related]